| 3.210 0.080 (2.56%) 10-19 17:35 |
|
| Open: | 3.150 |
| High: | 3.210 |
| Low: | 3.090 |
| Pre. close: | 3.130 |
| Volume: | 21,014 |
| Avg. volume: | 90,735 |
| MA (50): | 3.663 |
| MA (200): | 3.359 |
| Year high: | 5.100 |
| Year low: | 1.490 |
| Market cap: | 46(M) |
| EPS: | -0.22 |
| PE ratio: | -14.59 |
| SELL | BUY |
| HeikinAshi: | |
| Kaufmans AMA: | |
| Chandelier (20): | |
| MA (5): | |
| MA (50): | |
| MACD (26,12,9): | |
| Slow KDJ (14,3): | |
| RSI (14): | |
| CCI (20): |
Tue, 29 Sep 2026
THX PHARMA REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2026 - Actusnews
Wed, 09 Sep 2026
THX Pharma Exploits European Patent License for Batten-1 Until 2041 - Ideal Investisseur
Tue, 09 Jun 2026
THX Pharma, Biocodex and the Beyond Batten Disease Foundation Stand Together with the CLN3 Batten Community on… - Actusnews
Tue, 17 Feb 2026
THX Pharma appoints Julien Veys as Deputy CEO - PMLiVE
Wed, 11 Feb 2026
French biopharma duo THX Pharma and Biocodex strike rare diseases licensing deal worth up to €173M - European Biotechnology Magazine
Wed, 11 Feb 2026
Thx Pharma and Biocodex sign rare disease licensing deal - PharmaTimes
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.